NO20034581L - Procedure for autologous transplantation - Google Patents
Procedure for autologous transplantationInfo
- Publication number
- NO20034581L NO20034581L NO20034581A NO20034581A NO20034581L NO 20034581 L NO20034581 L NO 20034581L NO 20034581 A NO20034581 A NO 20034581A NO 20034581 A NO20034581 A NO 20034581A NO 20034581 L NO20034581 L NO 20034581L
- Authority
- NO
- Norway
- Prior art keywords
- surfactant
- procedure
- autologous transplantation
- hlb
- self
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 238000002054 transplantation Methods 0.000 title 1
- 239000004094 surface-active agent Substances 0.000 abstract 3
- 239000003354 cholesterol ester transfer protein inhibitor Substances 0.000 abstract 2
- 229940125881 cholesteryl ester transfer protein inhibitor Drugs 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/3654—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Det beskrives CETP-inhibitorer som har forbedret løselighet og biotilgjengelighet i en lipofil bærer, som omfatter en oppsluttbar olje, et lipofilt løsningsmiddel eller et overflateaktivt middel. Foretrukne blandinger er selv- emulgerende eller selv-mikroemulgerende og omfatter: 1) en CETP-inhibitor; 2) et med-løsningsmiddel; 3) et overflateaktivt middel som har en HLB på 1 til 8; 4) et overflateaktivt middel som har en HLB på 8-20; og 5) eventuelt en oppsluttbar olje.CETP inhibitors are described which have improved solubility and bioavailability in a lipophilic carrier, which comprises a absorbable oil, a lipophilic solvent or a surfactant. Preferred compositions are self-emulsifying or self-microemulsifying and comprise: 1) a CETP inhibitor; 2) a co-solvent; 3) a surfactant having an HLB of 1 to 8; 4) a surfactant having an HLB of 8-20; and 5) optionally a slurpable oil.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28325301P | 2001-04-12 | 2001-04-12 | |
| PCT/US2002/011497 WO2002083878A1 (en) | 2001-04-12 | 2002-04-12 | Method for autologous transplantation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20034581D0 NO20034581D0 (en) | 2003-10-10 |
| NO20034581L true NO20034581L (en) | 2003-12-09 |
Family
ID=23085209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20034581A NO20034581L (en) | 2001-04-12 | 2003-10-10 | Procedure for autologous transplantation |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1390471A4 (en) |
| JP (1) | JP2005502390A (en) |
| CN (1) | CN1514877A (en) |
| BR (1) | BR0208879A (en) |
| CA (1) | CA2444004A1 (en) |
| CZ (1) | CZ20033051A3 (en) |
| HU (1) | HUP0401450A3 (en) |
| IL (1) | IL158371A0 (en) |
| MX (1) | MXPA03009312A (en) |
| NO (1) | NO20034581L (en) |
| PL (1) | PL367295A1 (en) |
| RU (1) | RU2003132877A (en) |
| SK (1) | SK13892003A3 (en) |
| WO (1) | WO2002083878A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050209705A1 (en) * | 2004-03-09 | 2005-09-22 | Niederauer Gabriele G | Implant scaffold combined with autologous or allogenic tissue |
| US20060100138A1 (en) * | 2004-11-10 | 2006-05-11 | Olsen David R | Implantable collagen compositions |
| DE102005030614B4 (en) | 2005-06-30 | 2014-05-08 | Biotissue Ag | Cell-free graft, its use, process for its preparation, matrix thus produced with gel and process for the preparation of this matrix with gel |
| PL1937293T3 (en) | 2005-09-02 | 2014-03-31 | Ed Geistlich Soehne Ag Fuer Chemische Ind | Method of repairing meniscal tears |
| EP2698173A1 (en) | 2008-02-29 | 2014-02-19 | Coloplast A/S | Compositions and methods for augmentation and regeneration of living tissue in a subject |
| WO2009106642A1 (en) * | 2008-02-29 | 2009-09-03 | Coloplast A/S | Biosynthetic cartilaginous matrix and methods for their production |
| AU2013290152B2 (en) * | 2012-07-11 | 2016-11-03 | Osiris Therapeutics, Inc. | Porated cartilage products |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5788625A (en) * | 1996-04-05 | 1998-08-04 | Depuy Orthopaedics, Inc. | Method of making reconstructive SIS structure for cartilaginous elements in situ |
| US5759190A (en) * | 1996-08-30 | 1998-06-02 | Vts Holdings Limited | Method and kit for autologous transplantation |
| US6171340B1 (en) * | 1998-02-27 | 2001-01-09 | Mcdowell Charles L. | Method and device for regenerating cartilage in articulating joints |
-
2002
- 2002-04-12 CN CNA02811745XA patent/CN1514877A/en active Pending
- 2002-04-12 MX MXPA03009312A patent/MXPA03009312A/en not_active Application Discontinuation
- 2002-04-12 EP EP02726736A patent/EP1390471A4/en not_active Withdrawn
- 2002-04-12 BR BR0208879-7A patent/BR0208879A/en not_active IP Right Cessation
- 2002-04-12 RU RU2003132877/15A patent/RU2003132877A/en not_active Application Discontinuation
- 2002-04-12 SK SK1389-2003A patent/SK13892003A3/en unknown
- 2002-04-12 JP JP2002582217A patent/JP2005502390A/en active Pending
- 2002-04-12 CZ CZ20033051A patent/CZ20033051A3/en unknown
- 2002-04-12 IL IL15837102A patent/IL158371A0/en unknown
- 2002-04-12 PL PL02367295A patent/PL367295A1/en not_active Application Discontinuation
- 2002-04-12 CA CA002444004A patent/CA2444004A1/en not_active Abandoned
- 2002-04-12 HU HU0401450A patent/HUP0401450A3/en unknown
- 2002-04-12 WO PCT/US2002/011497 patent/WO2002083878A1/en not_active Ceased
-
2003
- 2003-10-10 NO NO20034581A patent/NO20034581L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20033051A3 (en) | 2004-05-12 |
| JP2005502390A (en) | 2005-01-27 |
| NO20034581D0 (en) | 2003-10-10 |
| WO2002083878A1 (en) | 2002-10-24 |
| EP1390471A4 (en) | 2005-04-13 |
| HUP0401450A2 (en) | 2004-11-29 |
| SK13892003A3 (en) | 2004-07-07 |
| CA2444004A1 (en) | 2002-10-24 |
| HUP0401450A3 (en) | 2006-11-28 |
| BR0208879A (en) | 2004-06-29 |
| RU2003132877A (en) | 2005-03-10 |
| PL367295A1 (en) | 2005-02-21 |
| MXPA03009312A (en) | 2004-03-10 |
| IL158371A0 (en) | 2004-05-12 |
| CN1514877A (en) | 2004-07-21 |
| EP1390471A1 (en) | 2004-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200301139A1 (en) | SELF-EMULATING PREPARATIONS OF THE INHIBITORS OF CHOLESTEROL ETHERUM PROTECTIVE | |
| DK1680097T3 (en) | Topical application compositions and methods for delivering an active agent to a substrate | |
| NO20034581L (en) | Procedure for autologous transplantation | |
| CY1112850T1 (en) | METHOD FOR PREVENTING SURGICAL INTERFERENCE | |
| NO20061396L (en) | New heterocyclic compounds as HSP90 inhibitors | |
| ATE365536T1 (en) | SOLVENT SYSTEMS FOR PHARMACEUTICAL PRODUCTS | |
| NO20031331L (en) | Substituted amino-aza-cycloalkanes useful for malaria | |
| NO20074908L (en) | Preparations containing fatty acids and / or derivatives thereof and a low temperature stabilizer | |
| CY1110240T1 (en) | NEW 2H-FIRE-3-ONE PRODUCERS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD FOR PREPARING THE ACTIVE INGREDIENT | |
| CY1106343T1 (en) | NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS | |
| ECSP066828A (en) | CONCENTRATED IN OLEAGINOUS BASE SUSPENSION | |
| AR029775A1 (en) | DERIVATIVES OF 1,2,3,4-TETRAHYDROCHINOLINES 4-CARBOXYAMIN-2-SUBSTITUTED, PROCEDURE FOR THEIR PREPARATION, CRYSTALLINE FORMS OF THE SAME AND METHOD OF TREATMENT OF THE ATEROSCLEROSIS THAT USES IT | |
| EA200300105A1 (en) | Nonsteroid Inflammation Inhibitors | |
| NO20062718L (en) | Aid for specified | |
| CY1106358T1 (en) | NEW BICYCLIC INHIBITORS OF HORMONE-SENSITIVE LIPASE | |
| DK1164857T3 (en) | Method and apparatus for processing a poultry year | |
| DK1171417T3 (en) | Process for the preparation of 3-aryloxy-3-arylpropylamines and intermediates thereof | |
| DK1246809T3 (en) | 5-aryl-1H-1,2,4-triazole compounds as inhibitor of cyclooxygenase-2 and pharmaceutical compositions containing them | |
| EA200501928A1 (en) | Pyrrolodihydroisoquinols as inhibitors of PDE10 | |
| EA200800546A1 (en) | BENZIMIDAZOLTHIOPHENE COMPOUNDS AS POLO-SIMILAR KINASE (PLK) INHIBITORS | |
| EA200600440A1 (en) | 4 - ((PHENOXYL) THYO) ENOXYACETIC ACIDS AND THEIR ANALOGUES | |
| NO20074718L (en) | BCRP / ABCG2 inhibitor | |
| DK1446210T3 (en) | Process for extraction and analysis of ingredients from organic material | |
| DK1272169T3 (en) | Use of 13-head as regulator of vascular biocompatibility and as inhibitor of cellular hyperplasia | |
| DE60112742D1 (en) | USE OF PYRAZONE DERIVATIVES FOR THE TREATMENT OF BARRENESS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |